Table of Contents

company-logo

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, it is involved in the marketing and distribution of imported pharmaceutical products, including Millibar for the treatment of high blood pressure; and development of oral insulin. Further, the company engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holding of gene invention rights. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.

Extrawell Pharmaceutical Dividend Announcement

• Extrawell Pharmaceutical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Extrawell Pharmaceutical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Extrawell Pharmaceutical Dividend History

Extrawell Pharmaceutical Dividend Yield

Extrawell Pharmaceutical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Extrawell Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:

Extrawell Pharmaceutical Financial Ratios

P/E ratio-0.79
PEG ratio0.50
P/B ratio0.12
ROE-19.86%
Payout ratio0.00%
Current ratio3.45
Quick ratio3.31
Cash Ratio2.23

Extrawell Pharmaceutical Dividend FAQ

Does Extrawell Pharmaceutical stock pay dividends?
Extrawell Pharmaceutical does not currently pay dividends to its shareholders.
Has Extrawell Pharmaceutical ever paid a dividend?
No, Extrawell Pharmaceutical has no a history of paying dividends to its shareholders. Extrawell Pharmaceutical is not known for its dividend payments.
Why doesn't Extrawell Pharmaceutical pay dividends?
There are several potential reasons why Extrawell Pharmaceutical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Extrawell Pharmaceutical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Extrawell Pharmaceutical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Extrawell Pharmaceutical a dividend aristocrat?
Extrawell Pharmaceutical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Extrawell Pharmaceutical a dividend king?
Extrawell Pharmaceutical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Extrawell Pharmaceutical a dividend stock?
No, Extrawell Pharmaceutical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Extrawell Pharmaceutical stocks?
To buy Extrawell Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Extrawell Pharmaceutical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.